EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A novel carcinogenic mouse model by site‐directed insertion of tandem human HRAS large DNA fragment into 15E1 site

Susu Liu iD, Yanwei Yang, Guitao Huo, Hao Yang Zhao, Chen Ling, YuYa Wang, Shijie Zhai, Xiaowei Sun, Wenda Gu, Yuan Cao, Wei Gong, Sanlong Wang und 1 weitere

Animal Models and Experimental Medicine · 2025

DOI: 10.1002/ame2.70086 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Animal Models and Experimental Medicine, 2025. Verfasst von Susu Liu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Animal Model Research, Institute for Laboratory Animal Resources, National Institutes for Food and Drug Control (NIFDC), Beijing, China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins p21(ras), Disease Models, Animal, Mutagenesis, Insertional. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Institutes for Food and Drug Control, State Key Laboratory of Drug Regulatory Science, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The precise insertion of large DNA fragments (>3–5 kb) remains one of the key obstacles in establishment of genetically modified murine models.

Methods

A 21 kb large DNA fragment containing three tandemly linked copies of the human HRAS gene was inserted into the genome of C57BL/6J mouse, generating a mouse model designated as KI.C57‐ras (or named NF‐hHRAS). Whole‐genome sequencing and Sanger sequencing were utilized to it confirm precise insertion and copy number. The stability of transgene expression among different generations was verified from multiple aspects using by digital PCR, western blot and DNA sequencing. To assess tumor susceptibility in the mouse model, N‐Nitroso‐N‐methylurea (MNU) was administered at a dosage of 75 mg/kg. Histopathological examinations were conducted using hematoxylin and eosin (H&E) staining.

Results

The HRAS DNA fragment was inserted into mouse chromosome 15E1 site, locating between 80 623 202 bp and 80 625 020 bp. NF‐hHRAS mice exhibited stable inheritance and displayed consistent phenotypes across individuals. Moreover, this mouse model exhibited a high susceptibility to carcinogens. Upon administration of MNU the earliest mortality onset was earlier than that of wild‐type littermates (day 65 vs. day 78 for male and day 56 vs. day 84 for female). Notably, 100% of the NF‐hHRAS transgenic mice developed tumors, with approximately 84% of male NF‐hHRAS mice exhibiting specific tumor types, such as squamous cell carcinoma or squamous cell papilloma, which was consistent with the previously reported carcinogenic rasH2 mouse model. The types of tumors and the target organs exhibited diversity in NF‐hHRAS mice, while the spontaneous tumor incidence remained low (1/50).

Conclusions

The NF‐hHRAS mice demonstrated excellent genetic stability, a reproducible phenotype, and high susceptibility to carcinogens, indicating their potential utility in non‐clinical safety evaluations of drugs as per the S1B guidelines issued by the ICH (The International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins p21(ras)Disease Models, AnimalMutagenesis, InsertionalAnimalsHumansMice, Inbred C57BLMice, TransgenicFemaleMaleMiceMethylnitrosoureaCarcinogens

Stichwörter der Autor:innen

ICH S1B guidelineKI.C57‐ras carcinogenic mouse modelhuman HRAS genelarge DNA fragment editingnon‐clinical carcinogenicity evaluation

Substanzen

Proto-Oncogene Proteins p21(ras)HRAS protein, humanMethylnitrosoureaCarcinogens

Autor:innen und Institutionen

  • Division of Animal Model Research, Institute for Laboratory Animal Resources, National Institutes for Food and Drug Control (NIFDC), Beijing, China.
  • National Rodent Laboratory Animal Resource Center, Beijing, China.
  • National Centre for Safety Evaluation of Drugs, Institute for Food and Drug Safety Evaluation, National Institutes for Food and Drug Control (NIFDC), Beijing, China.

ORCID-Profile: Susu Liu, Changfa Fan

Förderung

  • National Key R&D Program of China
  • National Institutes for Food and Drug Control, State Key Laboratory of Drug Regulatory Science
  • National Key Research and Development Program of China
  • National Institutes for Food and Drug Control

Zitieren

APA

Liu, S., Yang, Y., Huo, G., Yang Zhao, H., Ling, C., Wang, Y., Zhai, S., Sun, X., Gu, W., Cao, Y., Gong, W., Wang, S., & Fan, C. (2025). A novel carcinogenic mouse model by site‐directed insertion of tandem human HRAS large DNA fragment into 15E1 site. Animal Models and Experimental Medicine. https://doi.org/10.1002/ame2.70086

Vancouver

Liu S, Yang Y, Huo G, Yang Zhao H, Ling C, Wang Y, et al. A novel carcinogenic mouse model by site‐directed insertion of tandem human HRAS large DNA fragment into 15E1 site. Animal Models and Experimental Medicine. 2025. doi:10.1002/ame2.70086

BibTeX
@article{Liu2025,
  author = {Liu, Susu and Yang, Yanwei and Huo, Guitao and Yang Zhao, Hao and Ling, Chen and Wang, YuYa and Zhai, Shijie and Sun, Xiaowei and Gu, Wenda and Cao, Yuan and Gong, Wei and Wang, Sanlong and Fan, Changfa},
  title = {A novel carcinogenic mouse model by site‐directed insertion of tandem human HRAS large DNA fragment into 15E1 site},
  journal = {Animal Models and Experimental Medicine},
  year = {2025},
  doi = {10.1002/ame2.70086}
}
Kostenlos starten →